The crosstalk between gut microbiota and obesity and related metabolic disorders

Obesity and related metabolic diseases are currently a threat to global public health. The occurrence and development of these conditions result from the combined effects of multiple factors. The human gut is a diverse and vibrant microecosystem, and its composition and function are a focus of resea...

Full description

Saved in:
Bibliographic Details
Published in:Future microbiology 2016-06, Vol.11 (6), p.825-836
Main Authors: Xu, Wen-Ting, Nie, Yong-Zhan, Yang, Zhen, Lu, Nong-Hua
Format: Article
Language:English
Subjects:
20th century
Bacteria
Diseases
Gastrointestinal Microbiome
Gastrointestinal Tract - metabolism
Gastrointestinal Tract - microbiology
Genomes
gut microbiota
Health risks
Humans
intervention
Intestinal microflora
Irritable bowel syndrome
Liver diseases
metabolic disease
Metabolic Diseases - metabolism
Metabolic Diseases - microbiology
Metabolic disorders
Metabolites
Microbiota
Microorganisms
Obesity
Obesity - metabolism
Obesity - microbiology
Pathogenesis
Pathogens
Physiology
Public health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Obesity and related metabolic diseases are currently a threat to global public health. The occurrence and development of these conditions result from the combined effects of multiple factors. The human gut is a diverse and vibrant microecosystem, and its composition and function are a focus of research in the fields of life science and medicine. An increasing amount of evidence indicates that interactions between the gut microbiota and their genetic predispositions or dietary changes may be key factors that contribute to obesity and other metabolic diseases. Defining the mechanisms by which the gut microbiota influence obesity and related chronic metabolic diseases will bring about revolutionary changes that will enable practitioners to prevent and control metabolic diseases by targeting the gut microbiota.
ISSN:1746-0913
1746-0921
DOI:10.2217/fmb-2015-0024